This study tests an investigational drug called EN3835 against a placebo in 418 adults with painful Ledderhose disease (plantar fibromatosis). The main goal is to see if the drug reduces daily foot pain and improves walking and daily activities over 12 weeks. Participants cannot …
Phase: PHASE3 • Sponsor: Endo Pharmaceuticals • Aim: Symptom relief
Last updated Apr 29, 2026 15:04 UTC